Dysplasia in oral lichen planus: relevance, controversies and challenges. A position paper by González Moles, Miguel Ángel et al.
e541
Med Oral Patol Oral Cir Bucal. 2021 Jul 1;26 (4):e541-8. Dysplasia in oral lichen planus
Journal section: Oral Cancer and Potentially malignant disorders
Publication Types: Review
Dysplasia in oral lichen planus: 
relevance, controversies and challenges. A position paper
Miguel Ángel González-Moles 1,2,3, Saman Warnakulasuriya 3,4, Isabel González-Ruiz 1,2, Ángela Ayén 5, Lucía 
González-Ruiz 6, Isabel Ruiz-Ávila 2,7, Pablo Ramos-García 1,2
1 School of Dentistry, University of Granada, Granada, Spain
2 Instituto de Investigación Biosanitaria ibs. Granada, Granada, Spain
3 WHO Collaborating Group for Oral Cancer
4 Faculty of Dental, Oral & Craniofacial Sciences, King's College London, London, UK
5 Dermatology Service, San Cecilio Hospital Complex, Granada, Spain
6 Dermatology Service, Ciudad Real General University Hospital, Ciudad Real, Spain
7 Pathology Service, San Cecilio Hospital Complex, Granada, Spain
Correspondence:
Oral Medicine Department, School of Dentistry, University of Granada





Background: Patients with oral lichen planus (OLP) have an increased risk of oral cancer. For this reason, OLP is 
classified as an oral potentially malignant disorder. However, the precise personal (or individual) risk is unknown. 
Recent meta-analytical studies have reported that dysplastic OLP may transform to cancer in around 6% of cases, 
while the rate of transformation is lower (<1.5%) in non-dysplastic cases. The presence of epithelial dysplasia has 
emerged as the most powerful indicator for assessing cancer risk in oral potentially malignant disorders in routine 
practice. However, the general acceptance of epithelial dysplasia as an accompanying histologic feature in OLP is 
subject to great controversy. Many pathologists consider the presence of dysplasia as a criterion to exclude OLP 
when routinely reporting on this disease. This practice, widespread among oral pathology professionals, has re-
sulted in the underestimation of the potential for malignancy of OLP.
Material and Methods: A review of the literature was carried out in order to critically analyze the relevance, con-
troversies and challenges encountered across the diagnosis of epithelial dysplasia in OLP.
Results: 12 studies have been published examining dysplastic changes in OLP, reporting figures ranging from 0.54% 
to 25% of cases with dysplasia in the first diagnostic biopsy. The diagnosis of dysplasia in the OLP poses an ad-
ditional difficulty due to the fact that the affected oral epithelium per se develops changes related to autoimmune 
aggression. Among the most frequent histological features of OLP that develops dysplasia are basal cell hyperplasia 
with basaloid appearance, loss of basal cells polarity, cellular and nuclear pleomorphism and irregular stratification.
Conclusions: Epithelial dysplasia should not be considered an exclusion criterion for OLP; its evaluation requires 
experienced pathologists in this field.
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Introduction
Oral lichen planus (OLP) is currently classified as an 
oral potentially malignant disorder (OPMD) (1,2) with a 
global prevalence of around 1% (3). Several systematic 
reviews and meta-analyses have estimated the ratios for 
malignant transformation of OLP ranging from 0.44-
2.28% (1,4,5). On the aspects related to malignant trans-
formation of OLP, mainly the presence of epithelial dys-
plasia has generated considerable controversy (6). The 
origin of the aforementioned controversy arose from the 
Krutchkoff and Eisenberg’s research published several 
decades ago (7) who, meticulously reviewed a case series 
of OLP that transformed to cancer, established that the 
initial biopsy did not correspond with a diagnosis of OLP, 
but represented erroneous diagnoses of other lesions that 
clinically could appear as a mixture of red and white le-
sions showing epithelial dysplasia. They argued that, in 
response to dysplasia that was observed microscopically, 
these cases could have developed lichen-like histologi-
cal events sometime later, essentially an inflammatory 
lichenoid infiltrate. Those lesions were categorized by 
Krutchkoff’s group as an entity called “oral lichenoid dys-
plasia”, a term that is at the center of the controversy. The 
authors recommended that all “atypical” cases of OLP 
presenting with epithelial dysplasia should be excluded 
from studies examining the risk of malignancy of this 
lesion. Surprisingly, with a snowball effect and without 
further scientific evidence, this exclusion criterion was 
accepted by most experts reporting on OLP; the presence 
of epithelial dysplasia in a biopsy was established as an 
exclusion criterion in diagnostic pathology when report-
ing on OLP, i.e. if epithelial dysplasia is present, it is not 
OLP (8-10). The available evidence raises a key question 
regarding whether or not the detection of epithelial dys-
plasia invalidates the diagnosis of OLP. Nevertheless, the 
experience of many clinicians and pathologists shows 
that some cases of OLP clinically well documented may 
develop epithelial dysplasia along the course of its evolu-
tion (11), and this opinion is also shared by the authors of 
this paper (Fig. 1). The consideration of epithelial dys-
plasia as a criterion for excluding a diagnosis of OLP has 
resulted in misclassification of more serious OLP cases 
leading to a remarkable underestimation of the potential 
for malignant transformation of this disease (1,12).
Fig. 1: Two images of oral mucosa showing epithelial dysplasia are presented. A) belongs to an OLP lesion; B) cor-
responds to an oral epithelium in a patient without OLP in whom epithelial dysplasia has developed lichenoid events, 
especially a band-like inflammatory infiltrate, Civatte bodies, liquefaction degeneration of the basal layer and interface 
mucositis phenomena; C) These aspects can be seen in this figure which corresponds to an enlargement of the black-
framed space in figure b. Black arrows are pointing to Civatte bodies. The difficulty in evaluating epithelial dysplasia in 
OLP advises considering, in addition to the histological presentation, the data from the patient's medical history and the 
clinical appearance of the lesions.
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Discussion
- Molecular basis of epithelial dysplasia in OLP
The concept of oral epithelial dysplasia refers to an al-
teration of the morphology of the oral epithelium, de-
tectable under an optical miscroscopic observation in 
tissue samples stained with hematoxylin-eosin, reflect-
ing a disturbance of the epithelial architecture coupled 
with the presence of cellular atypia. Epithelial dyspla-
sia reveals a disordered epithelial maturation with an 
increase in cell proliferation. Currently, epithelial dys-
plasia is considered as the gold-standard for the evalu-
ation of the cancer progression risk of an OPMD (2). 
These morphological changes occur because of devel-
opment of genomic instability, i.e. the cell’s predispo-
sition to accumulate mutations and/or other genomic 
alterations affecting oncogenes and tumor suppressor 
genes, essentially as the consequence of an increased 
proliferative activity (25). Some molecular findings in 
OLP are common to those that develop in epithelial 
dysplasia found in other OPMD (26). Among them, 
stands out the loss of heterozygosity (LOH), an altera-
tion affecting the function of both alleles of a gene. 
LOH reaches its greatest importance when it affects 
the 3p and 9p chromosomal loci (27), where several 
important tumor suppressor genes (25) are located. 
LOH consequently leads to the loss of regulatory 
function of the cell cycle, favoring the cell to enter in 
an uncontrolled proliferation state with genomic in-
stability, development of new oncogenic summative 
events and contributing to a high risk of malignancy 
(25). Zhang et al. (27) reported that while OLP without 
dysplasia exhibits LOH in 6% of cases, in OLP with 
epithelial dysplasia LOH appears in more than 40 % of 
cases. These proportions are close to their findings in 
others dysplastic OPMD without lichenoid events. The 
authors conclude that OLP provides a fertile field for 
the development of dysplasia. The term "oral lichen-
oid dysplasia" has been used but this is confusing and 
should not be used. The features actually correspond to 
OLPs that have developed epithelial dysplasia in their 
evolution (28). The study of DNA ploidy has been used 
to assess the risk of malignant transformation of OLP, 
with promising results (28). It has also been reported 
in some studies (29) a significant association between 
aneuploidy and the presence and severity of epithelial 
dysplasia in OPMD, among which is OLP, indicating 
that the abnormal total nuclear DNA content may be a 
molecular event of epithelial dysplasia.
Data on immunohistochemical studies examining the 
expression of proteins involved in the cell cycle control, 
most of them encoded by tumor suppressor genes, also 
support the possibility that OLP may develop dysplasia 
through its evolution. Alterations in the function of cell 
cycle repressor proteins p53, CDKN1A, p16, CDK4 ac-
quire great relevance as links in the transition towards 
Material and Methods 
A review of the literature was carried out in order 
to meticulously analyze the implications of epithelial 
dysplasia in OLP. We searched MEDLINE/PubMed 
-as main electronic database- and Web of Science -for 
bibliometric analysis purposes- for studies published 
before the year 2020 (upper limit), with no lower 
date limit. Searches were conducted by combining 
thesaurus terms used by the databases (i.e., MeSH) 
with free terms, constructed to maximize sensitiv-
ity. In a first line general search, the root keywords 
combined were “oral lichen planus”, “oral lichenoid 
lesions”, “oral potentially malignant disorders” and 
“epithelial dysplasia”. In addition, several more spe-
cific searches were conducted combining relevant 
aspects of the subsections to be reviewed (physi-
ological molecular regulation, biological functions, 
oncogenic mechanisms, diagnostic and prognostic 
implications, oral oncogenesis, and therapeutic im-
plications). We also manually screened the reference 
lists of retrieved studies for additional relevant stud-
ies. Most of the studies were included or excluded 
according to an exhaustive analysis of the title, ab-
stract, year of publication, impact of the journal 
and number of citations received. Although these 
last two criteria may introduce a potential selection 
bias, its application is necessary when handling a 
large number of records (e.g., in this context, sim-
ply searching: ("Lichen Planus, Oral"[mh] OR "oral 
lichen planus"[all] OR "olp"[tiab] OR "oral lichenoid 
lesion"[all] OR "oll"[tiab] OR (“potentially”[all] AND 
“malignant”[all] AND disorder*[all]) OR “Mouth 
Neoplasms”[mh] OR malign*[all] or premalign*[all] 
or "Carcinoma, Squamous Cell"[mh] or "oscc"[tiab] 
or “transformation”[tiab] or "risk"[tiab] or "pro-
gression" [tiab]) AND (“dysplasia”[all]), more than 
20,000 registers were retrieved).
Results
Twelve studies have been published examining dys-
plastic changes in OLP (13-23), reporting figures 
ranging from 0.54% to 25% of cases with dysplasia in 
the first diagnostic biopsy, only one of them (24) did 
not find dysplasia. The diagnosis of dysplasia in the 
OLP poses an additional difficulty due to the fact that 
the affected oral epithelium per se develops changes 
related to autoimmune aggression. Among the most 
frequent histological features of OLP that develops 
dysplasia are basal cell hyperplasia with basaloid 
appearance, loss of basal cells polarity, cellular and 
nuclear pleomorphism and irregular stratification. In 
addition, to discuss some controversial aspects on the 
subject we have used at the discretion of the authors, 
when necessary other research papers that did not ap-
pear in the search strategy.
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malignancy of the OLP epithelium (30-32). Further-
more, an overexpression of the anti-apoptotic protein 
Bcl-2 in OLP epithelium (30,31) and OLP-associated 
infiltrating lymphocytes have also been demonstrated 
by immunohistochemical techniques (Fig. 2), which 
constitute a mechanism for maintaining autoimmune 
aggression (32). Overexpression of survivin, which 
acts as an apoptosis inhibitor, has also been reported 
in OLP (33). Moreover, down-regulation of apoptosis 
promoters like caspase-3 and Fas/FasL in OLP have 
been reported (32,34,35). Finally, activation of the pro-
proliferative pathway PI-3K (33) together with some 
proteins involved in this pro-proliferative pathways, as 
substance P and its receptor NK-1R (Fig. 2) (35), have 
been also demonstrated in the OLP epithelium. Many 
of these molecular mechanisms are probably activat-
ed as a consequence of actions linked to aggression 
mediated by the inflammatory infiltrate as it has been 
described with reference to nuclear factor kappa beta 
(NF kappa B), which is overexpressed in inflammato-
ry processes and also in cancer; also reported in head 
and neck squamous cell carcinomas and in OLP, where 
NF kappa B is related to the cytotoxic activity of the 
inflammatory infiltrate (36). Finally, matrix metallo-
proteinases proteins (MMP), especially MMP-2 and -9 
have been identified in OLP where it appears to play 
a role associated with the disruption of the basement 
membrane, with the death of keratinocytes, and with 
the process of exocytosis. Some other researchers have 
reported an increase in cell proliferation markers (Fig. 
2), i.e. expression -PCNA, Ki-67, cyclin D1- in OLP 
(32,34,35). We hypothesize (32) that this epithelial 
hyperproliferative response together with the suppres-
sion of apoptosis represents a mechanism for regenera-
tion of the damaged oral epithelium, as an attempt to 
avoid its loss of healing in erosive OLP, the most se-
vere form of the disease. However, the epithelium must 
pay a high price for establishing this protective hyper-
proliferative mechanism: the development of dysplasia 
with genomic instability and the risk of malignancy.
Fig. 2: Immunohistochemical expression of some proteins involved in cell cycle control 
in OLP: A) expression of the anti-apoptotic protein Bcl-2 in the OLP inflammatory in-
filtrate; B) expression of the pro-proliferative protein Substance P; C) expression of the 
proliferation marker Ki-67 in the basal layer of the epithelium in OLP.
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- The role of chronic inflammation
In recent years, the idea that chronic inflammation 
is an important risk factor for cancer is receiving 
significant attention, in this sense OLP is not an ex-
ception (37). Thus, infiltrating lymphocytes and their 
chemokines can be a powerful cancer promoting fac-
tors (Fig. 1). It is known that the macrophage inhibi-
tory factor, RANTES chemokine and cycloxygen-
ase-2 (COX-2) could be responsible for the apoptosis 
inhibition and for the increase in cell proliferation 
observed in OLP. In addition, COX-2 can also exert 
mutagenic effects on epithelial cells through the in-
duction of its carcinogenic metabolite malondialde-
hyde, derived from the involvement of COX-2 in the 
arachidonic acid metabolism (32). As a consequence 
of chronic inflammation, oral epithelium affected by 
lichen planus is exposed to mutagenic stimuli. The 
antiapoptotic mechanisms mentioned earlier, with 
loss of the function of some tumor suppressor genes 
related with LOH, and other mutagenic factors in the 
inflammatory infiltrate, constitutes a field change for 
the development of epithelial dysplasia and therefore 
risk of cancer.
- Frequency of presentation and difficulty in recog-
nizing dysplastic changes in OLP
The study of the presence of dysplasia in OLP has 
been essentially limited, as previously mentioned, 
by the widespread consideration of epithelial dys-
plasia as a diagnostic exclusion criterion of the dis-
ease (8,38). To date, 12 studies have been published 
examining dysplastic changes in OLP, only one of 
them (24) did not find dysplasia while the remain-
ing 11 studies reported figures ranging from 0.54% 
to 25% of cases with dysplasia in the first diagnos-
tic biopsy (13-23); It is interesting to note that some 
authors (22) have reported a significant increase in 
the frequency of epithelial dysplasia in sequential bi-
opsies, with 12.9% exhibiting dysplasia in the first 
biopsy and 48% in OLP cases in a subsequent bi-
opsy; the authors note the second biopsy was taken 
to assess the worsening of the clinical appearance. 
A recent retrospective regional study from Autralia 
that traced OLP cases in their cancer registry noted 
that only OLP cases that had dysplasia in the original 
biopsy reports had later developed malignancy (19). 
From these data it can be deduced that epithelial dys-
plasia is a likely phenomenon in OLP. Further studies 
and a revision of the diagnostic criteria of the disease 
are required to establish the true prevalence of this 
important risk marker for cancer progression. How-
ever, the evaluation of the presence of dysplasia and 
assigning a grade for dysplasia in our view needs a 
thorough discussion among the experts working in 
this field. The diagnosis of dysplasia in OLP poses an 
additional difficulty due to the fact that the affected 
oral epithelium per se develops changes related to 
autoimmune aggression - vacuolizing degeneration 
of the basal layer of the epithelium, Civatte bodies, 
interphase mucositis, etc.- that could be confused 
with some histologic features of dysplasia; this is es-
pecially relevant in cases of mild dysplasia in which 
the changes are confined to the lower third of epi-
thelium, where epithelial histological abnormalities 
(8) in OLP are mainly observed. This observation 
is further supported by studies reporting most fre-
quently lichenoid histological events in mild-moder-
ate dysplasia, and that lichenoid morphology disap-
pears as the severity of the dysplasia increases (39), 
probably as a consequence that the histological ap-
pearance of severe dysplasia/carcinoma in situ is so 
conclusive that do not allow the pathologist another 
alternative diagnosis. The studies that evaluate the 
frequency of specific histological events of dysplastic 
OLP (8,21,23) have shown that they primarily affect 
the basal epithelial layer - basal cell hyperplasia with 
basaloid appearance, loss of basal cells polarity, cel-
lular and nuclear pleomorphism, irregular stratifica-
tion -all of them could easily be confused with some 
characteristic features of OLP (Table 1)-. It has also 
been pointed out (39) that even been the band-like 
inflammatory infiltrate one of the most common and 
easily recognizable lichenoid events, the difficulty in 
its interpretation is based on the non-specific nature 
of a phenomenon that develops in epithelia express-
ing antigens, as commonly occurs in the oral mucosa. 
In addition, pathologists frequently assume histologi-
cal changes in epithelia attacked by inflammatory 
infiltrates as reactive, downplaying the importance 
they really deserve (36). Interface mucositis, is also 
a frequent misinterpreted lichenoid histological ap-
pearance, since it represents a common aspect to im-
mune responses in the oral epithelium. Civatte bod-
ies, which correspond to apoptotic keratinocytes, are 
easily confused with dyskeratotic cells (39). Another 
added difficulty stems from the known fact that epi-
thelial dysplasia dramatically modifies the architec-
ture and histological appearance of the oral epitheli-
um; so, the question is what remains of the histology 
of OLP once the dysplasia has been established, de-
veloped and progressed? (1). Due to the discussed 
complexities, OLP should be histologically evaluated 
by experienced pathologists in this field, preferably 
by two agreeing with consensus, and the final con-
sideration of a case as a dysplastic OLP should be the 
consequence of the weighted evaluation of the data of 
the clinical history, clinical presentation as presented 
by the clinician and histological evaluation. Often a 
MDT style clinicopath conference between the two 
specialists – a clinician and pathologist- may help to 
resolve these conflicting issues.
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- Importance of dysplasia in the malignant transforma-
tion of OLP
The meta-analytical results recently published by our 
research group are, in this regard, of relevance (1,4). 
Thus, although non dysplastic OLP may progress to 
cancer ranging from 0.44-2.28% of the cases (1,4,5), our 
analysis showed significantly higher ratios of malignan-
cy in OLP with dysplasia (6.22%) (1). We reported that 
the malignant transformation ratio of OLP has prob-
ably been underestimated by the exclusion of cases with 
dysplasia. Further studies are warranted to accurately 
assess the importance of dysplasia in the malignant 
transformation of this disease. In our meta-analysis we 
also noted that studies in which patients were followed 
for longer periods, reported significantly higher rates 
of malignancy vs. those that followed their patients for 
shorter periods or did not communicate their follow up 
periods; it is logical that dysplasia can appear at any 
time during the evolution of OLP. Some authors con-
tinue defending in recent papers (20) a disease category 
under the term "lichenoid dysplasia"; Although this 
creates controversy and disagreement, some positive 
aspects must also be recognized, such as to reinforce 
the concept of the potentially malignant nature of OLP. 
From our point of view, the dysplastic appearance in the 
context of a lichenoid tissue response has in itself the 
value in risk prediction indicating or pointing towards 
an increased risk of oral cancer development in an in-
dividual patient. This fact should be considered as the 
most relevant of the process.
- Future research
By studying sequential biopsies available in pathology 
archives, it should be possible for the researchers to sys-
tematically examine whether epithelial dysplasia arises 
in established cases of OLP, particularly among cases 
where the first biopsy demonstrated classical features of 
Study Histological features Frequency
De Jong et al. 1985
- Loss of polarity of the basal cells.
- The presence of more than one layer of cells having a basaloid appear-
ance.
- Increased nuclear-cytoplasmic ratio.
- Drop-shaped rete processes.
- Irregular epithelial stratification.
- Increased number of mitotic figures a few abnormal mitoses may be pres-
ent.




- Reduction of cellular cohesion.
- Keratinization of single cells or cell groups in the spinal cell layer.
25%
Patil et al. 2015
- Irregular epithelial stratification
- Abnormal variation in nuclear size (anisonucleosis)
- Loss of polarity of basal cells
- Abnormal variation in nuclear shape (nuclear pleomorphism)
- Basal cell hyperplasia
- Abnormal variation in the cell size (anisocytosis)
- Drop shaped rete ridges
- Abnormal variation in the cell shape (cellular pleomorphism)
- Increased number of mitotic figures
- Increased nuclear/cytoplasmic ratio
- Abnormally superficial mitosis
- Increased nuclear size
- Premature keratinisation in single cells (dyskeratosis)
- Atypical mitotic figures
- Keratin pearls within rete ridges
- Increased number and size of nucleoli
- Hyperchromasia
15.71%
Cheng et al. 2016
Characterized by various degree of atypical cellular changes (hyperchroma-
tism, pleomorphism, increased nuclear/cytoplasmicratio); may sometimes 
exhibit a band-like inflammatory infiltrate; however, the inflammatory cell 
infiltrate is often mixed in cell types.
͟
Table 1: Histological features of dysplastic OLP.
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OLP without dysplasia. Prospective studies could also 
be planned in centers systematically following up OLP 
cases for evaluating the development of epithelial dys-
plasia during disease evolution. As the presence of epi-
thelial dysplasia dramatically modifies the architecture 
and histological appearance of the oral epithelium, we 
propose to develop a web based atlas as an educational 
resource and for networking among oral pathologists. 
We propose to conduct a delphi style expert opinion poll 
among oral pathologists to make a formal assessment of 
criteria when reporting on OLP.
Conclusions
Here we present why epithelial dysplasia should not 
be considered as an exclusion criterion of OLP diag-
nosis; the diagnostic criteria for this disease should be 
reviewed taking into consideration the possibility of 
developing dysplasia and its association with the malig-
nant transformation. OLP should be followed for long 
periods, probably for life, and investigated by biopsy 
with the main objective of assessing the presence of 
epithelial dysplasia. The evaluation of epithelial dyspla-
sia in OLP, due to its complexity, requires pathologists 
with experience in this field taking into account the data 
from the patient's history and the clinical presentation 
of the lesions.
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